Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuthill

Showing results (491-500 of 537) with videos related to

Pageof 54
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinomaN Agarwal, J Brugarolas, P Ghatalia, et al.
Nature Medicine|October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trialsRoberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.
Cell Metabolism|April 10, 2009
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistanceCarine Chavey, Gwendal Lazennec, Sylviane Lagarrigue, et al.
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
Frontiers in Immunology|April 14, 2022
Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus DiseaseSarah Keep, Brigid Veronica Carr, Fabian Z X Lean, et al.
Nature Chemistry|May 16, 2018
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virusAurélie Mousnier, Andrew S Bell, Dawid P Swieboda, et al.
Journal of Hepatology|May 15, 2021
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysisEmmanuel Anandraj Selvaraj, Ferenc Emil Mózes, Arjun Narayan Ajmer Jayaswal, et al.
JU Open Plus|March 12, 2026
Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer-A Retrospective Observational Cohort StudyMatthew H V Byrne, Nithesh Ranasinha, Abhishek Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour NetworkRichard Colling, Andrew Protheroe, Mark Sullivan, et al.
Pageof 54

Showing results (491-500 of 537) with videos related to

Sort By:
Pageof 54
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2024
Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinomaN Agarwal, J Brugarolas, P Ghatalia, et al.
Nature Medicine|October 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trialsRoberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez, et al.
Cell Metabolism|April 10, 2009
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistanceCarine Chavey, Gwendal Lazennec, Sylviane Lagarrigue, et al.
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
Frontiers in Immunology|April 14, 2022
Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus DiseaseSarah Keep, Brigid Veronica Carr, Fabian Z X Lean, et al.
Nature Chemistry|May 16, 2018
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virusAurélie Mousnier, Andrew S Bell, Dawid P Swieboda, et al.
Journal of Hepatology|May 15, 2021
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysisEmmanuel Anandraj Selvaraj, Ferenc Emil Mózes, Arjun Narayan Ajmer Jayaswal, et al.
JU Open Plus|March 12, 2026
Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer-A Retrospective Observational Cohort StudyMatthew H V Byrne, Nithesh Ranasinha, Abhishek Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour NetworkRichard Colling, Andrew Protheroe, Mark Sullivan, et al.
Pageof 54